References
- Blackwell B. Tranylcypromine. Lancet 1963; i: 414
- Paykel E S., White J. A European study of views on the use of monoamine oxidase inhibitors. British Journal of Psychiatry 1989; 9–17, (Suppl 6)
- Goldman L S., Alexander R C., Luchins D J. Monoamine oxidase inhibitors and tricyclic antidepressants: Comparisons of their cardiovascular effects. Journal of Clinical Psychiatry 1986; 47: 225–229
- Medical Research Council. Clinical trial of the treatment of depressive illness. British Medical Journal 1965; i: 881–886
- Raskin A, Schulterbrandt J G., Reatig N, et al. Depression subtypes and responses to phenelzine, diazepam and a placebo. Archives of General Psychiatry 1974; 30: 66–75
- Tyrer P J. Towards rational prescribing with MAOI's. British Journal of Psychiatry 1976; 128: 354–360
- Paykel E S., Rowan P R., Parker R R., et al. Response to phenelzine and amitriptyline in subtypes of outpatient depression. Archives of General Psychiatry 1982; 39: 1041–1049
- Liebowitz M R., Quitkin F M., Stewart J W., et al. Phenelzine v. imipramine in atypical depression: A preliminary report. Archives of General Psychiatry 1984; 41: 669–677
- Davidson J RT, Giller E L., Zisook S, et al. An efficacy study of isocarboxazid and placebo in depression and its relationship to depressive nosology. Archives of General Psychiatry 1988; 45: 120–127
- Da Prada M, Kettler R, Keller H H., et al. Neurochemical profile of moclobemide, a short acting and reversible inhibitor of monoamine oxidase type A. Journal of Pharmacology and Experimental Therapeutics 1989; 248: 400–414
- Burgess C D., Mellsop G W. Interaction between moclobemide and oral tyramine in depressed patients. Fundamental Clinical Pharmacology 1989; 3: 47–52
- Korn A, Da Prada M, Raffesberg W, Allen S, Gasic S. Tyramine pressor effect in man with moclobemide. Journal of Neural Transmission 1988; 26: 55–71, (suppl)
- Gieschke R, Schmid-Burgk W, Amrein R. Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine. Journal of Neural Transmission 1988; 26: 97–104, (suppl.)
- Baumhackl U, Biziere K, Fischbach R, et al. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder: An Australian double-blind munticenter study. British Journal of Psychiatry 1989; 155: 78–83, (suppl 6)
- Versiani M, Oggero U, Alterwain P, et al. A double-blind comparative trial of moclobemide v. imipramine and placebo in major depressive episodes. British Journal of Psychiatry 1989; 155: 72–77, (suppl 6)
- Youdim M B. H., Da Prada M, Amrein R. The cheese effect and new reversible MAO-A inhibitors. Journal of Neural Transmission 1988; 26: 1–124, (suppl.)
- Tiller J W. G., Maguire K P., Davies B M. Tyramine pressor response with moclobemide - a reversible monoamine oxidase inhibitor. Psychiatry Research 1987; 22: 213–220
- Silverstone T. Psychotropic drugs, appetite and body weight. Psychophannacology and Food, M Sandler, T Silverstone. Oxford University Press, Oxford 1985; 139–145
- Zung W W. K. A Self-Rating depression scale. Archives of General Psychiatry 1965; 12: 63–70